bf/NYSE:AVNS_icon.jpeg

NYSE:AVNS

Avanos Medical, Inc.

  • Stock

USD

Last Close

19.47

10/05 20:00

Market Cap

889.51M

Beta: 0.93

Volume Today

133.89K

Avg: 242.17K

PE Ratio

−15.55

PFCF: 23.35

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
293.65M
-
284.35M
3.17%
293.15M
3.09%
287.85M
1.81%
181.80M
36.84%
106.25M
41.56%
133.65M
25.79%
157.40M
17.77%
159.60M
1.40%
170.30M
6.70%
176.75M
3.79%
average payables
110.35M
-
143.60M
30.13%
165.95M
15.56%
168.15M
1.33%
172.15M
2.38%
170.55M
0.93%
126.45M
25.86%
75.30M
40.45%
62M
17.66%
62.15M
0.24%
62.10M
0.08%
average receivables
193.50M
-
218.60M
12.97%
229.30M
4.89%
207.40M
9.55%
196.55M
5.23%
176.75M
10.07%
157.15M
11.09%
165.85M
5.54%
149.55M
9.83%
149.55M
0%
155.35M
3.88%
book value per share
44.70
-
32.04
28.31%
22.65
29.31%
23.66
4.44%
25.97
9.77%
27.48
5.83%
26.58
3.29%
26.29
1.10%
26.28
0.04%
27.53
4.77%
26.53
3.64%
capex per share
-1.05
-
-1.69
60.13%
-1.51
10.41%
-0.62
58.68%
-0.92
47.82%
-1.04
12.69%
-1.06
2.19%
-0.42
60.25%
-0.44
3.31%
-0.41
5.74%
-0.38
7.18%
capex to depreciation
-0.71
-
-0.92
29.81%
-1.08
17.11%
-0.45
58.54%
-0.73
62.68%
-1.47
101.87%
-1.37
6.44%
-0.47
65.66%
-0.55
16.45%
-0.40
26.21%
-0.39
4.57%
capex to operating cash flow
-0.22
-
-0.53
142.42%
-0.72
35.90%
-0.15
78.63%
-0.30
94.37%
0.34
212.56%
0.68
101.41%
8.08
1,089.64%
-0.24
102.98%
-0.21
11.74%
-0.55
158.75%
capex to revenue
-0.03
-
-0.05
60.72%
-0.04
4.75%
-0.02
59.13%
-0.07
286.50%
-0.08
6.57%
-0.07
3.64%
-0.03
61.04%
-0.03
0.20%
-0.02
16.55%
-0.03
12.32%
cash per share
0.95
-
3.20
237.71%
2.78
13.18%
2.44
12.23%
4.69
92.40%
8.15
73.53%
4.31
47.05%
2.33
45.92%
2.46
5.62%
2.72
10.52%
1.88
30.88%
days of inventory on hand
97.85
-
91.97
6.01%
106.13
15.39%
96.15
9.40%
121.05
25.89%
169.51
40.04%
180.28
6.35%
180.52
0.14%
144.25
20.09%
187.73
30.14%
204.98
9.19%
days payables outstanding
40.60
-
54.81
34.99%
57.12
4.23%
61.08
6.93%
227.48
272.42%
237.24
4.29%
102.56
56.77%
72.25
29.55%
54.13
25.08%
66.98
23.74%
70.71
5.57%
days sales outstanding
44.24
-
51.06
15.42%
52.09
2.03%
43.58
16.35%
121.15
178.02%
84.21
30.49%
85.70
1.77%
85.74
0.04%
64.31
24.99%
74.74
16.21%
77.41
3.58%
debt to assets
0.00
-
0.25
5,154.00%
0.29
14.83%
0.28
3.31%
0.26
5.34%
0.14
48.93%
0.18
33.84%
0.15
17.74%
0.12
20.94%
0.16
33.26%
0.11
31.82%
debt to equity
0.01
-
0.43
7,353.95%
0.55
28.40%
0.53
4.13%
0.48
8.99%
0.19
60.05%
0.26
34.69%
0.20
23.01%
0.15
25.08%
0.22
46.18%
0.15
32.56%
dividend yield
0.32
-
earnings yield
0.08
-
0.01
84.20%
-0.27
2,238.64%
0.02
108.43%
0.04
58.87%
0.03
25.87%
-0.03
205.20%
-0.01
56.65%
0.00
125.14%
0.04
1,176.10%
-0.06
248.59%
enterprise value
1.87B
-
2.60B
38.85%
2.01B
22.98%
2.19B
9.16%
2.52B
15.25%
1.98B
21.61%
1.72B
12.80%
2.33B
35.15%
1.74B
25.48%
1.42B
18.15%
1.17B
17.92%
enterprise value over ebitda
6.31
-
14.26
125.91%
12.38
13.18%
14.29
15.43%
133.46
834.23%
47.30
64.56%
-142.50
401.24%
-1.17K
717.69%
36.64
103.14%
11.57
68.43%
11.84
2.41%
ev to operating cash flow
8.38
-
17.60
110.10%
20.54
16.72%
11.59
43.57%
17.49
50.90%
-13.58
177.63%
-23.14
70.42%
-932.15
3,927.61%
19.89
102.13%
15.64
21.39%
36.01
130.27%
ev to sales
1.12
-
1.56
39.29%
1.27
18.20%
1.37
7.93%
4.12
200.07%
3.03
26.50%
2.47
18.46%
3.26
31.90%
2.33
28.46%
1.73
25.68%
1.73
0.04%
free cash flow per share
3.76
-
1.49
60.32%
0.58
60.85%
3.43
486.94%
2.16
37.03%
-4.13
291.14%
-2.63
36.29%
-0.47
81.93%
1.38
390.25%
1.53
10.76%
0.31
79.48%
free cash flow yield
0.09
-
0.03
64.22%
0.02
46.72%
0.09
430.28%
0.05
49.57%
-0.09
297.07%
-0.08
15.32%
-0.01
86.73%
0.04
484.10%
0.06
41.91%
0.01
75.24%
graham net net
-1.41
-
-12.26
770.14%
-10.63
13.27%
-12.38
16.42%
-12.03
2.81%
0.46
103.85%
-2.80
704.25%
-1.98
29.46%
-0.80
59.32%
-3.13
289.87%
-3.86
23.09%
graham number
57.82
-
20.49
64.56%
68.30
233.30%
21.32
68.78%
31.47
47.57%
27.45
12.77%
24.01
12.50%
18.35
23.61%
7.99
56.42%
25.83
223.04%
28.14
8.94%
income quality
1.45
-
5.46
277.01%
-0.23
104.20%
4.74
2,171.97%
1.82
61.67%
-2.53
239.25%
1.62
164.10%
0.09
94.34%
16.79
18,165.85%
1.80
89.28%
-3.27
281.82%
intangibles to total assets
0.63
-
0.61
4.03%
0.51
15.35%
0.58
12.61%
0.42
28.10%
0.52
24.78%
0.55
5.45%
0.57
4.85%
0.59
3.00%
0.60
1.32%
0.61
2.15%
interest coverage
2.25K
-
15.72
99.30%
-11.41
172.60%
2.67
123.42%
-1.36
151.03%
0.02
101.39%
-3.71
19,706.40%
-2.96
20.42%
2.70
191.26%
7.40
174.38%
3.49
52.79%
interest debt per share
0.26
-
13.80
5,249.17%
13.12
4.93%
13.13
0.05%
13.09
0.30%
5.81
55.63%
7.15
23.14%
5.53
22.65%
3.97
28.29%
6.18
55.88%
4.20
32.05%
inventory turnover
3.73
-
3.97
6.39%
3.44
13.34%
3.80
10.37%
3.02
20.56%
2.15
28.59%
2.02
5.97%
2.02
0.14%
2.53
25.14%
1.94
23.16%
1.78
8.42%
invested capital
0.01
-
0.43
7,353.95%
0.55
28.40%
0.53
4.13%
0.48
8.99%
0.19
60.05%
0.26
34.69%
0.20
23.01%
0.15
25.08%
0.22
46.18%
0.15
32.56%
market cap
1.91B
-
2.12B
10.95%
1.56B
26.45%
1.72B
10.72%
2.16B
25.41%
2.11B
2.18%
1.60B
24.12%
2.19B
36.71%
1.67B
23.96%
1.27B
23.90%
1.05B
17.64%
net current asset value
180.20M
-
-351.50M
295.06%
-268.90M
23.50%
-375.80M
39.75%
180.20M
147.95%
177.40M
1.55%
4.10M
97.69%
50.90M
1,141.46%
87.90M
72.69%
4.10M
95.34%
30.90M
653.66%
net debt to ebitda
-0.11
-
2.67
2,561.80%
2.77
3.79%
3.04
9.68%
19.11
529.23%
-3.27
117.12%
-9.93
203.28%
-68.65
591.64%
1.46
102.12%
1.24
14.87%
1.23
0.54%
net income per share
3.32
-
0.58
82.48%
-9.15
1,671.41%
0.85
109.33%
1.69
98.39%
1.22
28.11%
-0.96
179.16%
-0.57
40.99%
0.11
119.00%
1.08
896.00%
-1.33
223.16%
operating cash flow per share
4.81
-
3.18
33.95%
2.10
34.08%
4.05
93.38%
3.08
23.95%
-3.08
200.12%
-1.57
49.26%
-0.05
96.66%
1.81
3,570.22%
1.94
6.79%
0.70
64.13%
payables turnover
8.99
-
6.66
25.92%
6.39
4.05%
5.98
6.48%
1.60
73.15%
1.54
4.11%
3.56
131.32%
5.05
41.94%
6.74
33.48%
5.45
19.19%
5.16
5.28%
receivables turnover
8.25
-
7.15
13.36%
7.01
1.99%
8.38
19.54%
3.01
64.03%
4.33
43.86%
4.26
1.74%
4.26
0.04%
5.68
33.31%
4.88
13.95%
4.71
3.46%
research and ddevelopement to revenue
0.02
-
0.02
11.06%
0.02
2.10%
0.03
25.81%
0.06
141.98%
0.06
2.60%
0.05
15.67%
0.05
9.65%
0.04
11.15%
0.04
13.97%
0.04
8.26%
return on tangible assets
0.17
-
0.03
83.89%
-0.44
1,706.71%
0.05
110.40%
0.06
35.65%
0.07
5.47%
-0.06
186.41%
-0.04
32.28%
0.01
120.90%
0.07
783.46%
-0.09
233.50%
revenue per share
36.06
-
35.93
0.37%
33.80
5.94%
34.17
1.10%
13.07
61.75%
13.82
5.75%
14.66
6.05%
14.95
2.04%
15.48
3.52%
17.48
12.94%
14.45
17.36%
roe
0.07
-
0.02
75.56%
-0.40
2,322.83%
0.04
108.94%
0.07
80.74%
0.04
32.06%
-0.04
181.85%
-0.02
40.33%
0.00
119.01%
0.04
850.62%
-0.05
227.81%
roic
0.07
-
0.01
81.99%
-0.24
1,923.14%
0.04
115.58%
-0.01
128.52%
0.00
101.42%
-0.02
15,858.25%
-0.01
45.03%
0.01
140.16%
0.04
569.58%
0.05
28.30%
sales general and administrative to revenue
0.21
-
0.25
21.19%
0.25
0.30%
0.26
2.00%
0.53
103.73%
0.52
0.79%
shareholders equity per share
44.70
-
32.04
28.31%
22.65
29.31%
23.66
4.44%
25.97
9.77%
27.48
5.83%
26.58
3.29%
26.29
1.10%
26.28
0.04%
27.53
4.77%
26.53
3.64%
stock based compensation to revenue
0.00
-
0.00
32.09%
0.01
89.56%
0.01
3.78%
0.02
121.65%
0.02
21.87%
0.02
6.49%
0.02
12.47%
0.02
4.72%
0.02
9.38%
0.02
21.02%
tangible asset value
507.80M
-
-43.20M
108.51%
27.50M
163.66%
-96.30M
450.18%
301.80M
413.40%
345.40M
14.45%
280M
18.93%
296.30M
5.82%
321.10M
8.37%
220.80M
31.24%
200.70M
9.10%
tangible book value per share
10.92
-
-0.93
108.50%
0.59
163.59%
-2.07
450.07%
6.45
412.06%
7.32
13.48%
5.88
19.62%
6.20
5.38%
6.68
7.69%
4.71
29.48%
4.31
8.52%
working capital
274.70M
-
328.90M
19.73%
360.80M
9.70%
269.10M
25.42%
770.90M
186.47%
449.30M
41.72%
326M
27.44%
300.90M
7.70%
279.40M
7.15%
314M
12.38%
252.40M
19.62%

All numbers in USD (except ratios and percentages)